Devoted Health is currently in talks for a new funding round that could push its valuation to $25 billion. This move follows a significant jump from the $16 billion valuation the company secured earlier this year. The startup, which focuses on the Medicare Advantage market for elderly patients, is demonstrating how high investor interest remains for healthcare firms integrating artificial intelligence into their operations.
Founded in 2017 by Ed and Todd Park, the company operates as a hybrid entity that combines health insurance with direct medical care. Their internal proprietary tool, Orinoco, serves to coordinate care for members. This model has gained traction, with the company reporting 466,000 members as of January 2026, representing a 121% increase year-over-year. As a former COO of athenahealth and a former U.S. Chief Technology Officer, the founders are navigating a competitive landscape dominated by insurance giants and other venture-backed startups.
The Medicare Advantage sector continues to attract massive capital as enrollment rates for the private alternative to traditional Medicare climb. With federal government spending in this space reaching hundreds of billions annually, investors are betting on the ability of tech-driven companies to capture a larger share of this market while improving patient outcomes and medical economics. Devoted Health counts firms like Andreessen Horowitz and General Catalyst among its investors.
While the company has not provided official comments regarding these latest fundraising discussions, the move signals a strong push to scale operations within one of the largest segments of the healthcare industry. The interest highlights a broader trend where medical providers prioritize AI to gain efficiency in a high-growth, high-stakes market.